ACH
ACCENDRA HEALTH INC/VA/
NYSE · Healthcare · Medical - Distribution · US
$0.60
−7.00%Price chart
Aug 28Sep 2Sep 8Sep 11Sep 16Sep 21Sep 24Sep 29
Key dataSep 29, 2026
Open$0.66
From 52W high−89.03%
Volume1.20M
Market cap$46.49M
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataSep 29, 2026
Open
$0.66
From 52W high
−89.03%
Volume
1.20M
Market cap
$46.49M
ValuationView details →
P/E (Fwd)
10.4x
EV/EBITDA
7.9x
P/E (TTM)
—
RSI (14)
19.3
MomentumView details →
1D Return
−7.00%
YTD Return
−75.85%
Similar companies
Latest newsMore news →
Accendra Health Inc. announced that Kenneth Gardner-Smith will succeed Edward A. Pesicka as President and Chief Executive Officer effective October 5, 2026, with Pesicka retiring from the CEO and director roles and transitioning to an advisory consulting arrangement.19h agoAccendra Health Inc. appointed Kenneth Gardner-Smith as President and Chief Executive Officer, succeeding retiring Edward A. Pesicka, and named Scott Lloyd as Chief Commercial Officer effective October 5, 2026.12d agoAccendra Health announced it will not implement an at-the-market equity issuance program due to recent market conditions, abandoning the plan to issue modest amounts of equity over time to reduce debt.43d ago